Segmenting the Utility of ADCs in NSCLC: How These Agents Are Affecting Second-Line Standards

Keeping investigators on the edge of their seats, new data from clinical trials evaluating ADCs continue to impress.

Related Keywords

Washington ,United States , ,Johns Hopkins Sidney Kimmel Cancer Center ,Sibley Memorial Hospital ,Make Waves ,Cancer Field ,Their Own ,Prescription Drug User Fee Act ,Blood Brain Barrier ,Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins ,News ,Lung Cancer ,